STERIS plc
STE
Classifica tra le azioni
#1073
STERIS plc provides infection prevention products and services in the United... STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Prezzo delle azioni
$222.24
Capitalizzazione di mercato
$21.67B
Variazione (1 giorno)
0.03%
Variazione (1 anno)
-7.48%
Paese
IE
Scambia STERIS plc (STE)
Categoria
Healthcare
Rapporto P/E per STERIS plc (STE)
Rapporto P/E al October 2026 TTM: 26.50
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di STERIS plc, il rapporto P/E attuale (TTM) è 26.50. Alla fine del 2024, il rapporto P/E era 57.73.
Storico del rapporto P/E per STERIS plc da 2000 a 2026
Rapporto P/E alla fine di ogni anno
| Anno | Rapporto P/E | Cambia |
|---|---|---|
| 2026 (TTM) | 26.50 | -27.11% |
| 2025 | 36.35 | -37.03% |
| 2024 | 57.73 | -67.60% |
| 2023 | 178.19 | 84.29% |
| 2022 | 96.69 | 136.75% |
| 2021 | 40.84 | 40.30% |
| 2020 | 29.11 | -17.88% |
| 2019 | 35.45 | 29.90% |
| 2018 | 27.29 | -49.46% |
| 2017 | 53.99 | 19.05% |
| 2016 | 45.35 | 46.71% |
| 2015 | 30.91 | 42.11% |
| 2014 | 21.75 | 45.00% |
| 2013 | 15.00 | 10.64% |
| 2012 | 13.56 | -66.07% |
| 2011 | 39.96 | 159.24% |
| 2010 | 15.41 | 24.68% |
| 2009 | 12.36 | -43.79% |
| 2008 | 21.99 | 4.33% |
| 2007 | 21.08 | -12.03% |
| 2006 | 23.96 | 17.67% |
| 2005 | 20.36 | 7.34% |
| 2004 | 18.97 | -17.33% |
| 2003 | 22.95 | -27.34% |
| 2002 | 31.58 | -95.52% |
| 2001 | 705.00 | 1,000.49% |
| 2000 | 64.06 | 0.00% |
Rapporto P/E per aziende simili o concorrenti
| Azienda | P/E Ratio | Differenza del P/E Ratio | Il paese |
|---|---|---|---|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| 20.66 | -22.01% |
KR
|
Come leggere un P/E ratio?
Il rapporto Prezzo/Utile (P/E) misura la relazione tra il prezzo delle azioni di una società e i suoi utili per azione.
Un P/E basso ma positivo indica un'azienda che genera alti profitti rispetto alla sua valutazione attuale e potrebbe essere sottovalutata. Un'azienda con un P/E negativo elevato (vicino allo 0) segnala forti perdite rispetto alla valutazione.
Le aziende con un P/E superiore a 30 o negativo sono generalmente considerate "azioni di crescita", cioè ci si aspetta che crescano o diventino redditizie.
Le aziende con un P/E positivo inferiore a 10 sono considerate "azioni di valore", ossia già molto redditizie ma con scarse prospettive di crescita.